SYNVISC

Sinvysc is a Sanofi brand that develops SYNVISC® (hylan G-F 20) and SYNVISC-ONE® (hylan G-F 20), which are indicated for the treatment of pain in knee osteoarthritis in patients who have not responded adequately to non-pharmacological conservative treatment and simple analgesics, such as acetaminophen.